Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

FDA Grants Orphan Drug Designation to Semafore’s Chronic Lymphocytic Leukemia Treatment

By Pharmaceutical Processing | November 9, 2010

Semafore Pharmaceuticals announced today that the FDA has granted orphan drug designation to the company’s
SF1126 product candidate for the treatment of B-cell chronic lymphocytic
leukemia (CLL). In April 2010, the Company initiated an expansion of its
ongoing Phase I clinical study into this disease setting. SF1126 is a novel
peptidic prodrug that converts to LY294002, one of the most widely studied
small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and
mammalian target of rapamycin (mTOR).

 

“SF1126 is the first PI3K inhibitor to receive orphan drug
designation from the FDA for the treatment of CLL, which is an important
milestone for Semafore Pharmaceuticals,” said Joseph Garlich, Ph.D.,
Semafore’s Chief Scientific Officer. “We are committed to developing
SF1126 as a potential treatment for this disease and look forward to presenting
interim clinical data at ASH.”

 

SF1126 will be the subject of a poster presentation at the
52nd American Society of Hematology (ASH) Annual Meeting and
Exposition being held December 4-7, 2010 in Orlando, FL.
A summary of the presentation is below, and the full abstract can be accessed
on the ASH website at www.hematology.org.

 

 

Related Articles Read More >

FDA logo
Ultra Supplement announces recall for undeclared tadalafil
analyzing medical sample
Expert answers to nitrosamine impurity questions
Cardinal Health
Cardinal Health announces $124M settlement of investors’ opioid suit
FDA logo
FDA warns four companies over selling honey tainted with prescription drugs

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards